SwePub
Sök i SwePub databas

  Extended search

Träfflista för sökning "WFRF:(Van den Berg L) srt2:(1998-1999)"

Search: WFRF:(Van den Berg L) > (1998-1999)

  • Result 1-5 of 5
Sort/group result
   
EnumerationReferenceCoverFind
1.
  •  
2.
  • Van, den Berg M, et al. (author)
  • Toxic equivalency factors (TEFs) for PCBs, PCDDs, PCDFs for humans and wildlife
  • 1998
  • In: ENVIRONMENTAL HEALTH PERSPECTIVES. - : US DEPT HEALTH HUMAN SERVICES PUBLIC HEALTH SERVICE. ; 106:12, s. 775-792
  • Review (other academic/artistic)abstract
    • An expert meeting was organized by the World Health Organization (WHO) and held in Stockholm on 15-18 June 1997. The objective of this meeting was to derive consensus toxic equivalency factors (TEFs) for polychlorinated dibenzo-p-dioxins (PCDDs) and diben
  •  
3.
  •  
4.
  •  
5.
  • Ljung, R., et al. (author)
  • Port-A-Cath usage in children with haemophilia : Experience of 53 cases
  • 1998
  • In: Acta Paediatrica, International Journal of Paediatrics. - : Wiley. - 1651-2227. ; 87:10, s. 1051-1054
  • Journal article (peer-reviewed)abstract
    • Experience of the Port-A-Cath implantable venous access system in 53 children with severe or moderate haemophilia A or B from seven centres in five countries is reviewed. The cumulative duration of follow-up was 1578 months (median 30 months, range 1-114). Of the devices implanted, 70% (37/53) were used without complications (median follow-up 32 months; range 1-114) and the remaining 30% (16/53) were associated with various types of complication: infection, bacteraemia or septicaemia in 56% (9/16) of cases, i.e. a rate of 0.07 per follow-up year or 0.19 per 1000 patient days, or various technical complications occurring after a median of 32 months (range 4-75) of uncomplicated use in the remaining 44% (7/16). Of the patients with inhibitors, 64% (7/11) manifested complications. Both doctors and parents considered that the Port-A-Cath device can be used with an acceptable frequency and severity of complications, and that it enables regular prophylactic or on-demand home treatment of children with haemophilia to be begun at an early age.
  •  
Skapa referenser, mejla, bekava och länka
  • Result 1-5 of 5

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view